-9%

est. 2Y upside i

HealthcareSeries B

Rank

#3131

Sector

Healthcare Supply Chain Software

Est. Liquidity

~2Y

Data Quality

Data: Low

Lumere is a subsidiary of GHX, slated for acquisition by Veritas Capital in 2026, offering a possible liquidity event within 2 years.

Last updated: July 3, 2026

Bull (10%)+56%

Lumere maintains current multiple of 7.4x due to GHX/Veritas acquisition creating IPO or strategic sale liquidity, with revenue reaching $21.1M in 24 months.

Base (55%)+5%

Exit multiple converges to 5x (midpoint of public comp range), yielding exit value of $105.3M; common stock recovers modest after preference.

Bear (35%)-50%

Multiple compresses to 3x due to incumbent competition (Oracle, Palantir), exit value $63.2M; preference stack consumes 20% of exit, common worth $50.5M.

Est. time to liquidity~1.5 years

Preference Stack Risk

high

Funding Intensity

20%

Total funding of $20.1M represents 20.1% of estimated $100M valuation, creating a high preference overhang.

Dilution Risk

low

As a subsidiary of GHX, further fundraises are unlikely; no dilution expected within 2 years.

Secondary Liquidity

none

No secondary market exists as Lumere is a private subsidiary of GHX.

View all 6 open roles at Lumere →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Lumere's data — designed to show you've done your homework.

  • 1

    “How does Lumere's evidence-based software differentiate from Oracle's integrated AI inventory management?”

  • 2

    “What is the current annualized net dollar retention and how has it trended since the GHX acquisition?”

  • 3

    “Given the Veritas acquisition, what is the expected timeline for liquidity and how will employee equity be treated?”

Community

Valuation Sentiment

Our model estimates -9% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.